“Polymeric Nanoparticle-Mediated Delivery of Oncolytic Measles Virus for Targeted Therapy in Cervical Cancer”. Pharmaceutical Communications 3, no. 1 (June 29, 2024): 45–53. Accessed April 23, 2026. https://rootspress.org/journals/pharma/article/view/887.